Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This drug is a topical combination of three sunscreen agents: **zinc oxide**, **avobenzone**, and **ensulizole**. Zinc oxide is a physical (mineral) sunscreen that provides broad-spectrum protection by reflecting and scattering both UVA and UVB radiation. Avobenzone is a chemical sunscreen agent that primarily absorbs long-wavelength UVA rays, though it is known to be photounstable and often requires stabilization. Ensulizole (also known as phenylbenzimidazole sulfonic acid) is a water-soluble chemical sunscreen agent that primarily absorbs UVB radiation. Together, these ingredients provide broad-spectrum protection against skin damage, sunburn, and premature aging caused by solar radiation. This combination is typically found in over-the-counter (OTC) sunscreen lotions and moisturizers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zinc oxide + avobenzone + ensulizole.